Ranexa 500 mg


prolonged-release tablets
scheduling status
S3
registration number
52/7.1.4/0338
What Ranexa 500 mg contains
Ranolazine.
other ingredients
Hypromellose Magnesium stearate Methacrylic acid-ethyl acrylate copolymer (1:1) Microcrystalline cellulose Sodium hydroxide. Film coating for RANEXA 500 mg: Opadry II Orange containing: Carnauba wax Iron oxide red (E172) Iron oxide yellow (E172) Polyethylene glycol Polyvinyl alcohol Talc Titanium dioxide.
Therapeutic classification
Other cardiac preparations, ATC code: C01EB18.
© 2026 SAHPRA. ALL RIGHTS RESERVED